ArticleNature medicine2024

Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial.

Nadia Harbeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.